Ignite Creation Date:
2024-05-05 @ 12:04 PM
Last Modification Date:
2024-10-26 @ 9:20 AM
Study NCT ID:
NCT00234026
Status:
COMPLETED
Last Update Posted:
2012-06-05
First Post:
2005-10-05
Brief Title:
Gemcitabine in Treating Patients With Newly Diagnosed Relapsed or Chemotherapy-Resistant Mantle Cell Lymphoma
Sponsor:
Swiss Group for Clinical Cancer Research
Organization:
Swiss Group for Clinical Cancer Research
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Lymphoma |